(HealthDay)—Following U.S. Preventive Services Task Force (USPSTF) recommendations against routine prostate-specific antigen (PSA) screening, there has been a decrease in utilization of digital rectal examination and PSA ...
Sep 20, 2016
0
1
Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.
Apr 16, 2013
0
0
PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...
Jan 23, 2019
0
3
The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA) that provides evidence-based pharmacologic and non-pharmacologic recommendations ...
Dec 3, 2018
0
2
(AP) -- John Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer - and only the last one offered what made the most sense to the California man: Keep a close watch on ...
Dec 19, 2011
0
0
Annual cancer tests are becoming a thing of the past. New guidelines out Wednesday for cervical cancer screening have experts at odds over some things, but they are united in the view that the common practice of getting a ...
Oct 19, 2011
0
0
Should middle-aged men get routine blood tests for prostate cancer? An influential health panel that once said no now says maybe. It says certain men may benefit as long as they understand the potential harms.
Apr 11, 2017
0
1
(HealthDay)—A headline-grabbing report earlier this week claimed that new cases of advanced prostate cancer in the United States had skyrocketed 72 percent in the past decade.
Jul 21, 2016
1
2
In the past, all forms of metastatic prostate cancer have been considered incurable. In recent years, the FDA has approved six drugs for men with metastatic disease, all of which can increase survival. In a study published ...
Apr 18, 2017
0
6
Risankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently published in Rheumatology.
Jan 11, 2023
0
5
